Bioceltix S.a.
BCX
Rank in Stocks
#19653
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals... Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The companyโs products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
Share Price
$17.22
Last synced: 2026-11-16
Market Cap
$95.26M
Change (1 day)
-2.06%
Change (1 year)
-30.27%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Bioceltix S.a. (BCX)
Category
Healthcare
EPS for Bioceltix S.a. (BCX)
EPS as of June 2026 TTM: $-0.87
According to Bioceltix S.a.'s latest financial reports, its current EPS (TTM) is $-0.87. At the end of 2025 the company had an EPS of $-0.84, a decrease compared to its 2024 EPS of $-0.80.
EPS history for Bioceltix S.a. from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.87 | 3.67% |
| 2025 | $-0.84 | 5.56% |
| 2024 | $-0.80 | -10.12% |
| 2023 | $-0.89 | 45.72% |
| 2022 | $-0.61 | 76.89% |
| 2021 | $-0.34 | 35.15% |
| 2020 | $-0.25 | 97.90% |
| 2019 | $-0.13 | 100.62% |
| 2018 | $-0.06 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,898.35% |
US
|
|
| $-7.07 | 711.90% |
US
|
|
| $-5.29 | 507.49% |
AU
|
|
| $12.73 | -1,562.13% |
BE
|
|
| $21.56 | -2,575.88% |
NL
|
Questions about Bioceltix S.a.'s earnings per share (EPS)
What is Bioceltix S.a.'s earnings per share (EPS)?
Bioceltix S.a.'s earnings per share (EPS) over the last twelve months is $-0.87, as of Jun 2026.
What was Bioceltix S.a.'s earnings per share (EPS) in 2025?
In 2025, Bioceltix S.a.'s earnings per share (EPS) was $-0.84, compared with $-0.80 in 2024.
How has Bioceltix S.a.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Bioceltix S.a.'s earnings per share (EPS) was highest in 2020 ($-0.25) and lowest in 2023 ($-0.89).
How does Bioceltix S.a.'s earnings per share (EPS) compare with similar companies?
Bioceltix S.a.'s earnings per share (EPS) ($-0.87) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.